Fig. 2: Associations between prior symptoms and seroprevalence of SARS-CoV 2 IgG antibodies. | Nature Communications

Fig. 2: Associations between prior symptoms and seroprevalence of SARS-CoV 2 IgG antibodies.

From: SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

Fig. 2

Odds ratios of seropositivity for individually reported symptoms. Odds ratios were calculated using two-sided Fisher’s exact test with n = 2149 independent individuals. No adjustment for multiple comparisons was applied. Data are presented as odds ratios and 95% confidence intervals. Source data are available as Source Data file.

Back to article page